Amalgamated Bank Geron Corp Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Geron Corp stock. As of the latest transaction made, Amalgamated Bank holds 18,144 shares of GERN stock, worth $60,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,144

Previous 18,144 -0.0%

Holding current value

$60,600

Previous $77,000 6.49%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$3.1 - $5.09 $3,658 - $6,006	1,180 Added 6.96%	18,144 $77,000
Q1 2024 Apr 23, 2024	SELL	$1.75 - $3.44 $82,442 - $162,058	-47,110 Reduced 73.52%	16,964 $56,000
Q4 2023 Feb 06, 2024	SELL	$1.74 - $2.31 $8,783 - $11,660	-5,048 Reduced 7.3%	64,074 $135,000
Q3 2023 Nov 08, 2023	BUY	$2.11 - $3.28 $11,986 - $18,633	5,681 Added 8.95%	69,122 $147,000
Q2 2023 Aug 11, 2023	BUY	$1.97 - $3.69 $22,495 - $42,136	11,419 Added 21.95%	63,441 $203,000
Q1 2023 May 02, 2023	SELL	$2.14 - $3.4 $4,382 - $6,963	-2,048 Reduced 3.79%	52,022 $113,000
Q3 2022 Nov 09, 2022	BUY	$1.67 - $2.94 $1,063 - $1,872	637 Added 1.19%	54,070 $127,000
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $19,731 - $27,358	16,581 Added 44.99%	53,433 $83,000
Q1 2022 Jun 30, 2022	SELL	$0.99 - $1.6 $2,625 - $4,243	-2,652 Reduced 6.71%	36,852 $50,000
Q4 2021 Feb 15, 2022	SELL	$1.22 - $1.72 $1,337 - $1,885	-1,096 Reduced 2.7%	39,504 $48,000
Q3 2021 Oct 29, 2021	SELL	$1.2 - $1.5 $2,209 - $2,761	-1,841 Reduced 4.34%	40,600 $56,000
Q2 2021 Aug 16, 2021	BUY	$1.25 - $1.83 $22,442 - $32,855	17,954 Added 73.32%	42,441 $60,000
Q3 2020 Oct 30, 2020	BUY	$1.59 - $2.19 $13,718 - $18,895	8,628 Added 54.4%	24,487 $43,000
Q2 2020 Aug 10, 2020	SELL	$1.05 - $2.18 $12,310 - $25,558	-11,724 Reduced 42.5%	15,859 $35,000
Q1 2020 May 13, 2020	SELL	$0.89 - $1.49 $1,315 - $2,202	-1,478 Reduced 5.09%	27,583 $33,000
Q4 2019 Feb 13, 2020	BUY	$1.27 - $1.54 $4,563 - $5,533	3,593 Added 14.11%	29,061 $40,000
Q3 2019 Nov 13, 2019	SELL	$1.15 - $1.59 $296 - $410	-258 Reduced 1.0%	25,468 $34,000
Q2 2019 Aug 14, 2019	BUY	$1.37 - $2.02 $182 - $268	133 Added 0.52%	25,726 $36,000
Q1 2019 May 15, 2019	BUY	$1.01 - $1.83 $894 - $1,621	886 Added 3.59%	25,593 $42,000
Q4 2018 Feb 15, 2019	BUY	$0.98 - $1.85 $24,212 - $45,707	24,707 New	24,707 $25,000
Q3 2018 Nov 14, 2018	SELL	$1.76 - $6.38 $43,164 - $156,469	-24,525 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$3.29 - $4.82 $14,900 - $21,829	4,529 Added 22.65%	24,525 $84,000
Q1 2018 May 22, 2018	SELL	$1.81 - $5.98 $950 - $3,139	-525 Reduced 2.56%	19,996 $85,000
Q4 2017 Feb 13, 2018	BUY	$1.8 - $2.32 $2,466 - $3,178	1,370 Added 7.15%	20,521 $37,000
Q3 2017 Nov 09, 2017	BUY	$1.99 - $2.65 $38,110 - $50,750	19,151	19,151 $42,000

Others Institutions Holding GERN

# of Institutions

274

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.26B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Geron Corp Transaction History